A Clinical and Metabolic Study of Acute Intoxication with Cannabis Sativa and its Role in the Model Psychoses
Journal of Mental Science October 1, 1958 DOI: 10.1192/bjp.104.437.972 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Clinical study Peer reviewed |
|---|---|
| Population | Healthy subjects (historical study) |
| Intervention | Cannabis |
| Topics | Cannabis LSD Mescaline |
| Keywords | Cannabis sativa Hashish Narcotic Hallucinogen Psychotomimetic Pharmacology Drug Delta-9-tetrahydrocannabinol |
| Citations | 184 |
| Key points | Oral doses of cannabis produce mental disturbances similar to those caused by mescaline and lysergic acid, which resemble schizophrenia symptoms and may serve as a research tool for studying psychoses. |
Abstract
This paper describes an inquiry into the effects of giving oral doses of the narcotic drug variously known as hashish, marihuana and, in South Africa, dagga. The drug is a preparation from the plant Cannabis sativa whose narcotic effect has been known for centuries. The writer's interest in it was inspired by the work in recent years on the mental disturbances produced by the active principles of other plants, e.g. mescaline and lysergic acid. Because of the similarity of these changes to those occurring in conditions such as schizophrenia, some workers have suggested that these “model psychoses” could be used as a research tool in attempts to elucidate the mechanisms and causes of the naturally occurring psychoses. Although there has been a great deal of work on mescaline and lysergic acid, cannabis has not received much attention. This may be because its chemistry is still not fully worked out and preparations of the plant are difficult to standardize and vary in their potency.
In the evidence
This study is part of the evidence base for a synthesis in the library. Here is how each one recorded it.
-
State of the evidence: Mescaline Supports
Oral cannabis produced mental disturbances similar to those caused by mescaline and lysergic acid, resembling schizophrenia symptoms and potentially serving as a research tool for psychoses.
Synthesized
Citations in the library
Cited by 26
- Drug Induced Psychosis The British Journal of Psychiatry February 1, 1996
- Marihuanann Psychosis JAMA October 13, 1969
- Cannabis and Psychosis Through the Lens of DSM-5 International Journal of Environmental Research and Public Health October 28, 2019
- Cannabinoid ‘model’ psychosis, dopamine–cannabinoid interactions and implications for schizophrenia Cambridge University Press eBooks May 27, 2004
- Is “cannabis psychosis” a distinct category? European Psychiatry 1992
and 21 more in the library